AU2003200722A1 - Compositions and methods for the treatment of tumor - Google Patents

Compositions and methods for the treatment of tumor

Info

Publication number: AU2003200722A1
Authority: AU; Australia
Prior art keywords: tumor; compositions; treatment; methods
Prior art date: 1999-03-08
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Granted

Application number

AU2003200722A

Other versions

AU2003200722B2 (en

AU2003200722C1 (en

Inventor

Avi J Ashkenazi

Audrey Goddard

Paul J Godowski

Austin L Gurney

Kenneth J Hillan

Scot A Marsters

James Pan

Robert M Pitti

Margaret Ann Roy

Victoria Smith

Donna M Stone

Colin K Watanabe

William L Wood

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Genentech Inc

Original Assignee

Genentech Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-03-08

Filing date

2003-02-25

Publication date

2003-05-01

1999-03-08 Priority claimed from PCT/US1999/005028 external-priority patent/WO1999046281A2/en

2000-02-11 Priority claimed from AU28794/00A external-priority patent/AU756400B2/en

2003-02-25 Application filed by Genentech Inc filed Critical Genentech Inc

2003-05-01 Application granted granted Critical

2003-05-01 Publication of AU2003200722A1 publication Critical patent/AU2003200722A1/en

2003-05-01 Publication of AU2003200722C1 publication Critical patent/AU2003200722C1/en

2006-02-02 Publication of AU2003200722B2 publication Critical patent/AU2003200722B2/en

2020-02-11 Anticipated expiration legal-status Critical

Status Ceased legal-status Critical Current

Applications Claiming Priority (28)

Application Number	Priority Date	Filing Date	Title
PCT/US1999/005028 WO1999046281A2 (en)	1998-03-10	1999-03-08	Novel polypeptides and nucleic acids encoding the same
AUPCT/US1999/005028		1999-03-08
US12397299P	1999-03-11	1999-03-11
US60/123972		1999-03-11
US13345999P	1999-05-11	1999-05-11
US60/133459		1999-05-11
AUPCT/US1999/012252		1999-06-02
US14065399P	1999-06-22	1999-06-22
US14065099P	1999-06-22	1999-06-22
US60/140650		1999-06-22
US60/140653		1999-06-22
US14475899P	1999-07-20	1999-07-20
US60/144758		1999-07-20
US14569899P	1999-07-26	1999-07-26
US60/145698		1999-07-26
US14622299P	1999-07-28	1999-07-28
US60/146222		1999-07-28
US14939599P	1999-08-17	1999-08-17
US60/149395		1999-08-17
US15168999P	1999-08-31	1999-08-31
US60/151689		1999-08-31
AUPCT/US1999/020111		1999-09-01
AUPCT/US1999/021090		1999-09-15
AUPCT/US1999/028313		1999-11-30
AUPCT/US1999/028634		1999-12-01
AUPCT/US1999/028301		1999-12-01
AU26008/00		2000-01-05
AU28794/00A AU756400B2 (en)	1999-03-08	2000-02-11	Compositions and methods for the treatment of tumor

Related Parent Applications (1)

Application Number	Title	Priority Date	Filing Date
AU28794/00A Division AU756400B2 (en)	1999-03-08	2000-02-11	Compositions and methods for the treatment of tumor

Publications (3)

Publication Number	Publication Date
AU2003200722A1 true AU2003200722A1 (en)	2003-05-01
AU2003200722C1 AU2003200722C1 (en)	2003-05-01
AU2003200722B2 AU2003200722B2 (en)	2006-02-02

Family

ID=27578504

Family Applications (3)

Application Number	Title	Priority Date	Filing Date
AU2003200722A Ceased AU2003200722B2 (en)	1999-03-08	2003-02-25	Compositions and methods for the treatment of tumor
AU2003200731A Ceased AU2003200731C1 (en)	1999-03-08	2003-02-25	Compositions and methods for the treatment of tumor
AU2003200740A Ceased AU2003200740C1 (en)	1999-03-08	2003-02-26	Compositions and methods for the treatment of tumor

Family Applications After (2)

Application Number	Title	Priority Date	Filing Date
AU2003200731A Ceased AU2003200731C1 (en)	1999-03-08	2003-02-25	Compositions and methods for the treatment of tumor
AU2003200740A Ceased AU2003200740C1 (en)	1999-03-08	2003-02-26	Compositions and methods for the treatment of tumor

Country Status (10)

Country	Link
EP (7)	EP1626058B1 (en)
JP (6)	JP2004520003A (en)
KR (1)	KR100512819B1 (en)
AT (6)	ATE422536T1 (en)
AU (3)	AU2003200722B2 (en)
CA (5)	CA2479498A1 (en)
DK (5)	DK1607402T3 (en)
ES (6)	ES2298896T3 (en)
PT (5)	PT1632499E (en)
WO (1)	WO2001053486A1 (en)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO1999040100A1 (en)	1998-02-09	1999-08-12	Human Genome Sciences, Inc.	45 human secreted proteins
US7160679B1 (en)	1998-05-21	2007-01-09	Diadexus, Inc.	Method of diagnosing, monitoring, and staging lung cancer
US6593133B1 (en) *	1998-07-06	2003-07-15	Nsgene A/S	Neurotrophic factors
CA2348757A1 (en) *	1998-12-16	2000-06-22	Genentech, Inc.	Secreted and transmembrane polypeptides and nucleic acids encoding the same
AU2507700A (en)	1999-01-15	2000-08-01	Biogen, Inc.	Antagonists of tweak and of tweak receptor and their use to treat immunological disorders
US8410248B2 (en)	1999-03-12	2013-04-02	Human Genome Sciences Inc.	HWBAO62 polypeptides
EP1820860A3 (en) *	1999-06-02	2008-03-19	Genentech, Inc.	Methods and compositions for inhibiting neoplastic cell growth
US20030119113A1 (en)	1999-07-20	2003-06-26	Genentech, Inc.	Secreted and transmembrane polypeptides and nucleic acids encoding the same
US6943146B2 (en)	2000-05-08	2005-09-13	Biogen Idec Ma Inc.	Method for promoting neovascularization
US7208151B2 (en)	2001-09-12	2007-04-24	Biogen Idec Ma Inc.	Tweak receptor agonists as anti-angiogenic agents
EP1392855A4 (en) *	2000-12-07	2005-05-25	Millennium Pharm Inc	Methods and compositions for the diagnosis and treatment of viral disease using 55092
WO2003023408A1 (en) *	2001-09-07	2003-03-20	Genfit	Compositions and methods for aa4rp assay
FR2843395A1 (en) *	2002-08-12	2004-02-13	Genfit S A	New synthetic peptide from apolipoprotein AIV related protein, useful for raising antibodies, used for diagnosis and treatment of disorders of lipid metabolism
US20050123925A1 (en) *	2002-11-15	2005-06-09	Genentech, Inc.	Compositions and methods for the diagnosis and treatment of tumor
WO2003072773A1 (en) *	2002-02-08	2003-09-04	Seikagaku Corporation	Fused protein having glucuronyl transferase activity
WO2003070936A1 (en) *	2002-02-20	2003-08-28	Yamanouchi Pharmaceutical Co., Ltd.	Novel polypeptide
EP1361433A3 (en) *	2002-04-09	2005-02-23	Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo	Method for estimating therapeutic efficacy of tumor necrosis factor (TNF)
SI1997512T1 (en)	2002-04-09	2014-03-31	Biogen Idec Ma Inc.	Methods for treating TWEAK-related conditions
WO2004003165A2 (en) *	2002-06-28	2004-01-08	Imclone Systems Incorporated	Novel polynucleotide and polypeptide sequences and uses thereof
CA2489515C (en) *	2002-06-29	2013-01-22	Genentech, Inc.	Methods and compositions for modulating and detecting wisp activity
US7455834B2 (en)	2002-06-29	2008-11-25	Genentech, Inc.	Methods and compositions for modulating and detecting WISP activity
EP1539807A4 (en) *	2002-08-07	2006-09-06	Curagen Corp	Therapeutic polypeptides, nucleic acids encoding same, and methods of use
WO2005028633A2 (en)	2003-09-17	2005-03-31	Isis Pharmaceuticals, Inc.	Modulation of rankl expression
MX2007000783A (en)	2004-07-20	2007-04-09	Genentech Inc	Compositions and methods of using angiopoietin-like 4 protein.
US8604185B2 (en)	2004-07-20	2013-12-10	Genentech, Inc.	Inhibitors of angiopoietin-like 4 protein, combinations, and their use
ATE472333T1 (en)	2004-08-19	2010-07-15	Biogen Idec Inc	REFOLDING OF TRANSFORMING GROWTH FACTOR BETA FAMILY PROTEINS
DK2529619T3 (en)	2005-02-17	2016-01-11	Biogen Ma Inc	Treatment of neurological disorders
CN101171035A (en) *	2005-03-07	2008-04-30	健泰科生物技术公司	Methods and compositions for modulating TWEAK and FN14 activity
CA2607697C (en)	2005-05-10	2015-01-06	Biogen Idec Ma Inc.	Treating and evaluating inflammatory disorders
WO2006138219A2 (en)	2005-06-13	2006-12-28	Biogen Idec Ma Inc.	Methods of diagnosis / prognosis of inflammatory conditions
TWI501774B (en)	2006-02-27	2015-10-01	Biogen Idec Inc	Treatments for neurological disorders
AU2008247637B2 (en)	2007-05-01	2013-12-05	Biogen Ma Inc.	Compositions and methods for increasing vascularization
AU2008269689A1 (en) *	2007-06-27	2008-12-31	Auckland Uniservices Limited	Polypeptides and polynucleotides for artemin and related ligands, and methods of use thereof
US9255148B2 (en)	2009-09-03	2016-02-09	Cancer Research Technology Limited	CLEC14A inhibitors

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5411860A (en) *	1992-04-07	1995-05-02	The Johns Hopkins University	Amplification of human MDM2 gene in human tumors
JP3399948B2 (en) *	1992-06-26	2003-04-28	ザトラスティーズオブプリンストンユニバーシティ	Method for detecting precancerous cells or cancer cells using P90 antibody or probe
WO1995014772A1 (en) *	1993-11-12	1995-06-01	Kenichi Matsubara	Gene signature
WO1999038881A1 (en) *	1998-01-30	1999-08-05	Human Genome Sciences, Inc.	67 human secreted proteins
WO1999066041A1 (en) *	1998-06-16	1999-12-23	Human Genome Sciences, Inc.	94 human secreted proteins
JP2001512013A (en) *	1997-08-01	2001-08-21	ジェンセット	5'EST of secreted protein expressed in prostate
US6030831A (en) *	1997-09-19	2000-02-29	Genetech, Inc.	Tie ligand homologues
CA2322425A1 (en) *	1998-03-02	1999-09-10	Millennium Pharmaceuticals, Inc.	Novel fdrg protein and nucleic acid molecules and uses therefor
DE19818620A1 (en) *	1998-04-21	1999-10-28	Metagen Gesellschaft Fuer Genomforschung Mbh	New polypeptides and their nucleic acids, useful for treatment of bladder tumor and identification of therapeutic agents
AU4187499A (en) *	1998-05-14	1999-11-29	Chiron Corporation	Human genes and gene expression products v
AU4643699A (en) *	1998-06-24	2000-01-10	Compugen Ltd.	Angiopoietin-like growth factor sequences
WO2000004135A2 (en) *	1998-07-16	2000-01-27	Incyte Pharmaceuticals, Inc.	Human scad-related molecules, scrm-1 and scrm-2
WO2000006728A2 (en) *	1998-07-28	2000-02-10	Incyte Pharmaceuticals, Inc.	Phosphorylation effectors
WO2000011015A1 (en) *	1998-08-24	2000-03-02	Alphagene, Inc.	Secreted proteins and polynucleotides encoding them
WO2001053455A2 (en) *	1999-12-23	2001-07-26	Hyseq, Inc.	Novel nucleic acids and polypeptides
WO2000034477A2 (en) *	1998-12-11	2000-06-15	Incyte Pharmaceuticals, Inc.	Neuron-associated proteins
JP2004507202A (en) *	1999-03-31	2004-03-11	キュラジェン　コーポレイション	Nucleic acid containing an open reading frame encoding a polypeptide; "ORFX"
CA2373915A1 (en) *	1999-06-02	2000-12-07	Genentech, Inc.	Methods and compositions for inhibiting neoplastic cell growth
AU1916101A (en) *	1999-11-12	2001-06-06	Human Genome Sciences, Inc.	19 human secreted proteins
CA2402563A1 (en) *	1999-12-23	2001-07-26	Hyseq, Inc.	Novel nucleic acids and polypeptides

2000
- 2000-02-11 DK DK05018356T patent/DK1607402T3/en active
- 2000-02-11 KR KR10-2001-7011391A patent/KR100512819B1/en not_active Expired - Fee Related
- 2000-02-11 EP EP05018357A patent/EP1626058B1/en not_active Expired - Lifetime
- 2000-02-11 CA CA002479498A patent/CA2479498A1/en not_active Abandoned
- 2000-02-11 CA CA002479494A patent/CA2479494C/en not_active Expired - Fee Related
- 2000-02-11 CA CA002479476A patent/CA2479476C/en not_active Expired - Fee Related
- 2000-02-11 EP EP05018356A patent/EP1607402B1/en not_active Expired - Lifetime
- 2000-02-11 DK DK05018354T patent/DK1632499T3/en active
- 2000-02-11 PT PT05018354T patent/PT1632499E/en unknown
- 2000-02-11 CA CA002479511A patent/CA2479511A1/en not_active Abandoned
- 2000-02-11 ES ES05018358T patent/ES2298896T3/en not_active Expired - Lifetime
- 2000-02-11 EP EP05018358A patent/EP1623990B1/en not_active Expired - Lifetime
- 2000-02-11 EP EP05018354A patent/EP1632499B9/en not_active Expired - Lifetime
- 2000-02-11 PT PT05018358T patent/PT1623990E/en unknown
- 2000-02-11 EP EP05018353A patent/EP1626084B1/en not_active Expired - Lifetime
- 2000-02-11 ES ES05018353T patent/ES2321954T3/en not_active Expired - Lifetime
- 2000-02-11 ES ES05018357T patent/ES2296029T3/en not_active Expired - Lifetime
- 2000-02-11 DK DK05018355T patent/DK1623989T3/en active
- 2000-02-11 CA CA002365610A patent/CA2365610A1/en not_active Abandoned
- 2000-02-11 AT AT05018353T patent/ATE422536T1/en not_active IP Right Cessation
- 2000-02-11 ES ES05018355T patent/ES2289630T3/en not_active Expired - Lifetime
- 2000-02-11 AT AT05018355T patent/ATE364628T1/en not_active IP Right Cessation
- 2000-02-11 DK DK05018357T patent/DK1626058T3/en active
- 2000-02-11 ES ES05018354T patent/ES2290834T3/en not_active Expired - Lifetime
- 2000-02-11 PT PT05018356T patent/PT1607402E/en unknown
- 2000-02-11 EP EP05018355A patent/EP1623989B1/en not_active Expired - Lifetime
- 2000-02-11 WO PCT/US2000/003565 patent/WO2001053486A1/en not_active Ceased
- 2000-02-11 JP JP2001553947A patent/JP2004520003A/en active Pending
- 2000-02-11 DK DK05018358T patent/DK1623990T3/en active
- 2000-02-11 AT AT05018354T patent/ATE363489T1/en not_active IP Right Cessation
- 2000-02-11 AT AT05018358T patent/ATE380195T1/en not_active IP Right Cessation
- 2000-02-11 EP EP00907270A patent/EP1173563A1/en not_active Withdrawn
- 2000-02-11 PT PT05018355T patent/PT1623989E/en unknown
- 2000-02-11 AT AT05018356T patent/ATE348108T1/en not_active IP Right Cessation
- 2000-02-11 ES ES05018356T patent/ES2279473T3/en not_active Expired - Lifetime
- 2000-02-11 PT PT05018357T patent/PT1626058E/en unknown
- 2000-02-11 AT AT05018357T patent/ATE377025T1/en not_active IP Right Cessation
2002
- 2002-12-26 JP JP2002378517A patent/JP2004201652A/en active Pending
- 2002-12-26 JP JP2002378692A patent/JP2004201653A/en active Pending
- 2002-12-27 JP JP2002380537A patent/JP2004229504A/en active Pending
- 2002-12-27 JP JP2002379711A patent/JP2004201654A/en active Pending
- 2002-12-27 JP JP2002379406A patent/JP2004229503A/en active Pending
2003
- 2003-02-25 AU AU2003200722A patent/AU2003200722B2/en not_active Ceased
- 2003-02-25 AU AU2003200731A patent/AU2003200731C1/en not_active Ceased
- 2003-02-26 AU AU2003200740A patent/AU2003200740C1/en not_active Ceased

Publication	Publication Date	Title
AU2495200A (en)	2000-09-28	Compositions and methods for the treatment of tumor
AU2003200740A1 (en)	2003-06-12	Compositions and methods for the treatment of tumor
AU2003200731A1 (en)	2003-05-01	Compositions and methods for the treatment of tumor
AU2003200722A1 (en)	2003-05-01	Compositions and methods for the treatment of tumor
AU2212299A (en)	1999-07-26	Compositions and methods for the treatment of tumor
AU4205100A (en)	2000-11-14	Methods and compositions for the treatment of pancreatitis
AU6147401A (en)	2001-11-26	Compositions and methods for the treatment of cancer
AU1656501A (en)	2001-06-06	Compositions and methods for the therapy and diagnosis of prostate cancer
KR100510795B1 (en)	2005-08-30	Compositions and Methods for the Treatment of Tumor
AU3632600A (en)	2000-12-05	Compositions and methods for the treatment of immune related diseases
AU6062900A (en)	2001-01-22	Substituted indole compounds and their use for the treatment of cancer
IL141426A0 (en)	2002-03-10	Compositions and methods for the treatment of tumor
IL143212A0 (en)	2002-04-21	Compositions and methods for the treatment of tumor
AU1878201A (en)	2001-07-16	Composition for the treatment of damaged tissue
AU3896899A (en)	1999-11-29	Compositions for the treatment of tumors, and uses thereof
AU3434601A (en)	2001-06-12	Compositions and methods for the treatment of immune related diseases
AU2001255730A1 (en)	2001-11-07	Methods and compositions for the treatment of cardiac indications
AU4228000A (en)	2000-11-14	Methods and compositions for the treatment and prevention of lung disease
AU2001271284A1 (en)	2001-12-17	Compositions and methods for the therapy and diagnosis of pancreatic cancer
AU2001296224A1 (en)	2002-02-18	Compositions and methods for the therapy and diagnosis of pancreatic cancer
AU2566201A (en)	2001-07-09	Compounds and methods for the treatment of pain
AUPQ367699A0 (en)	1999-11-18	Treatment of cancer
AU5552400A (en)	2001-01-09	Treatment of cancer
AU2420101A (en)	2001-07-09	Method and composition for the treatment of pain
AU4452900A (en)	2000-10-23	Compositions and methods for the therapy and diagnosis of prostate cancer